Pediatric Radiology

, Volume 41, Issue 9, pp 1183–1197

Characterization of pediatric liver lesions with gadoxetate disodium

Authors

  • Arthur B. Meyers
    • Department of Radiology, MLC 5031Cincinnati Children’s Hospital Medical Center
    • Department of Radiology, MLC 5031Cincinnati Children’s Hospital Medical Center
  • Suraj Serai
    • Department of Radiology, MLC 5031Cincinnati Children’s Hospital Medical Center
  • James I. Geller
    • Department of Hematology-OncologyCincinnati Children’s Hospital Medical Center
  • Daniel J. Podberesky
    • Department of Radiology, MLC 5031Cincinnati Children’s Hospital Medical Center
Pictorial Essay

DOI: 10.1007/s00247-011-2148-6

Cite this article as:
Meyers, A.B., Towbin, A.J., Serai, S. et al. Pediatr Radiol (2011) 41: 1183. doi:10.1007/s00247-011-2148-6

Abstract

Gadoxetate disodium (Gd-EOB-DTPA) is a relatively new hepatobiliary MRI contrast agent. It is increasingly used in adults to characterize hepatic masses, but there is little published describing its use in children. The purpose of this paper is to describe our pediatric MRI protocol as well as the imaging appearance of pediatric liver lesions using gadoxetate disodium. As a hepatocyte-specific MRI contrast agent, Gd-EOB-DTPA has the potential to improve characterization and provide a more specific diagnosis of pediatric liver masses.

Keywords

Pediatric liver tumorsPediatric liver MRIGadoxetate disodium

Copyright information

© Springer-Verlag 2011